SIGMA DIAGNOSTICS CO2ALKALINE BUFFER

K963538 · Sigma Diagnostics, Inc. · JFL · Oct 11, 1996 · Clinical Chemistry

Device Facts

Record IDK963538
Device NameSIGMA DIAGNOSTICS CO2ALKALINE BUFFER
ApplicantSigma Diagnostics, Inc.
Product CodeJFL · Clinical Chemistry
Decision DateOct 11, 1996
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.1160
Device ClassClass 2

Intended Use

The Sigma Diagnostics CO₂ Alkaline Buffer, Procedure Number C7683, is used to measure carbon dioxide concentrations in serum or plasma on the SYNCHRON CX®3 System.

Device Story

Reagent buffer for in vitro diagnostic measurement of CO₂ in serum/plasma; used on SYNCHRON CX®3 System. Principle: enzymatic/chemical reaction to quantify bicarbonate/dissolved CO₂. Used in clinical laboratory settings by trained technicians. Output: quantitative CO₂ concentration (mmol/L). Clinicians use results to assess acid-base balance and electrolyte status, aiding diagnosis of metabolic/respiratory disorders.

Clinical Evidence

Bench testing only. Comparison study with predicate using serum samples yielded correlation coefficient of 0.992 and regression equation y = 0.95x + 1.54. Precision testing (within-run and total) showed %CV < 6.5%. Linearity established from 5.0 to 40.0 mmol/L.

Technological Characteristics

Chemical reagent buffer for automated clinical chemistry analyzer. Operates via colorimetric/enzymatic reaction principle on SYNCHRON CX®3 System. Linear range: 5.0-40.0 mmol/L.

Indications for Use

Indicated for the determination of plasma CO₂ content as part of an electrolyte profile to assess metabolic or respiratory acidosis or alkalosis in patients with conditions such as diabetes mellitus, glomerulonephritis, pyloric obstruction, or diarrhea.

Regulatory Classification

Identification

A bicarbonate/carbon dioxide test system is a device intended to measure bicarbonate/carbon dioxide in plasma, serum, and whole blood. Bicarbonate/carbon dioxide measurements are used in the diagnosis and treatment of numerous potentially serious disorders associated with changes in body acid-base balance.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} OCT 11 1996 K963538 510(K) NOTIFICATION Sigma Diagnostics 545 South Ewing Avenue St. Louis, MO 63103 CX®3 CO₂ Alkaline Buffer Procedure Number C7683 August 31, 1996 # SUMMARY OF SAFETY AND EFFECTIVENESS Carbon dioxide (CO₂) in serum or plasma exists primarily as dissolved CO₂ and bicarbonate anion (HCO₃⁻).¹ The CO₂ content is decreased in metabolic acidosis and respiratory alkalosis, whereas the level is increased in metabolic alkalosis and respiratory acidosis.² In pathologic conditions such as in diabetes mellitus, glomerulonephritis, pyloric obstruction, or diarrhea, acidosis or alkalosis can be anticipated.³ Therefore, determination of plasma CO₂ content as part of an electrolyte profile helps establish whether, and to what degree, the anticipated change has occurred in the above patients. The safety and effectiveness of Sigma Diagnostics CO₂ Alkaline Buffer, Procedure Number C7683, are demonstrated by its substantial equivalency to Beckman CO₂ Alkaline Buffer Kit, Part No. 443320. Both CO₂ alkaline buffers are used to measure carbon dioxide concentrations in serum or plasma on the SYNCHRON CX®3 System, and the reaction principles for both are identical. In comparison studies, a correlation coefficient of 0.992 and a regression equation of y = 0.95x + 1.54 was obtained with serum samples. With-in run precision and total precision on serum samples demonstrated %CV’s of less than 6.5 %. The Sigma Diagnostics CO₂ Alkaline Buffer has been determined to be linear from 5.0 to 40.0 mmol/L on the SYNCHRON CX®3 System. # REFERENCES 1. Clinical Chemistry, LA Kaplan, AJ Pesce, Editors, CV Mosby Company, St. Louis (MO) 1989 2. Hydrogen Ion Concentration in Body Fluids. IN Contarow and Trumper Clinical Biochemistry, 7th ed., AL Latner, Editor, Saunders, Philadelphia, 1975, p 399 3. Tietz, NW, Prudent EL, Siggaard-Anderson O: Electrolytes, Blood Gases, and Acid-Base Balance. IN Textbook of Clinical Chemistry, NW Tietz, Editor, Saunders, Philadelphia, 1986, p 1188
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...